Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Motion Sickness Medications and Vestibular Time Constant

NCT03270839 is registered in ClinicalTrials.gov with Medical Corps, Israel Defense Force as lead sponsor.

NCT NCT03270839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03270839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Motion Sickness Medications and Vestibular Time Constant
Lead sponsor
Medical Corps, Israel Defense Force
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2017
Completion date
January 1, 2020
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drug reaction